Perceptive Advisors Acquires Significant Stake in Invivyd Inc: A Strategic Move in Biotechnology Sector

PERCEPTIVE ADVISORS LLC acquired 21.79 million shares of Invivyd Inc at $2.53 per share, representing a 1.57% position in its portfolio. The firm, known for strategic investments in biotechnology, has a $3.45 billion equity portfolio with significant holdings in companies like Ascendis Pharma AS and Celcuity Inc. Invivyd Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based solutions for infectious diseases. Despite current financial challenges, the acquisition highlights the firm's confidence in Invivyd Inc's long-term potential.